Ferritin (µg/L) · general population older than 2 years of age (including pregnant women), in Kenya and Mexico
1 finding from 1 review
Any adverse effects (including constipation, nausea, vomiting, heartburn or diarrhoea, as measured by trialists) · general population older than 2 years of age (including pregnant women), in Kenya and Mexico
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Relief of burning/discomfort (symptom relief; pain intensity) · People with primary burning mouth syndrome (BMS), that is, oral mucosal pain with no dental or medical cause for such symptoms
1 finding from 1 review
Interventions for treating burning mouth syndrome 2016 · Cochrane All outcomesshort-term (up to 3 months)
SoF5 Dietary supplements vs placebo. Symptom relief short-term: insufficient or contradictory evidence regarding benefit of any evaluated dietary supplement; 628 participants (12 RCTs); very low. Subgroups: ALA without…
12 studies · 628 participants
Very low
Myocardial infarction · people with or without existing cardiovascular disease, men and women
Homocysteine‐lowering interventions (Vitamin B6 (pyridoxine;… showed no clear difference in myocardial infarction compared with placebo or standard care (high certainty).
1 finding from 1 review
Stroke · people with or without existing cardiovascular disease, men and women
Homocysteine‐lowering interventions (Vitamin B6 (pyridoxine;… leads to lower stroke compared with placebo or standard care (high certainty).
1 finding from 1 review
Death by any cause · people with or without existing cardiovascular disease, men and women
Homocysteine‐lowering interventions (Vitamin B6 (pyridoxine;… showed no clear difference in death by any cause compared with placebo or standard care (high certainty).
1 finding from 1 review
Adverse events · people with or without existing cardiovascular disease, men and women
Homocysteine‐lowering interventions (Vitamin B6 (pyridoxine;… showed no clear difference in adverse events compared with placebo or standard care (high certainty).
1 finding from 1 review
Ulcer healing · people with diabetes and foot ulcers
The review found no eligible studies for this question.
2 findings from 1 review
Quality of life · people with diabetes and foot ulcers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events (death) · people with diabetes and foot ulcers
It is very uncertain whether oral nutritional supplement with 20 g protein per 200 mL bottle, 1… changes adverse events (death) compared with placebo (very low certainty).
1 finding from 1 review
Development of any new foot ulcers · people with diabetes and foot ulcers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Amputation · people with diabetes and foot ulcers
It is very uncertain whether oral nutritional supplement with 20 g protein per 200 mL bottle, 1… changes amputation rate compared with placebo (very low certainty).
1 finding from 1 review
Intervention not reported
Mifepristone vs vitamin B
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Grip strength ‐ Vitamin D · health problem or population
1 finding from 1 review
no estimate extracted
1 study · 1 participants
Low
Reported behavioural changes on vitamin or mineral supplement intake: number of women with adequate use of folic acid supplement · people with infertility
Preconception lifestyle advice on a combination of topics showed no clear difference in reported behavioural changes on vitamin or mineral supplement… compared with routine care or attention control (low certainty).
1 finding from 1 review
Intervention not reported
Vitamin D(1 RCT; 18 participants) · people with non‐alcohol‐related fatty liver disease (NAFLD)
It is very uncertain whether the intervention changes vitamin D(1 RCT; 18 participants) (very low certainty).
1 finding from 1 review
OR 1.3 [0.03, 58.38]
Studies not reported
Very low
Intervention not reported
Amino acids plus vitamin C(1 trial; 191 participants) · people with non‐alcohol‐related fatty liver disease (NAFLD)
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Amino acids + vitamin C(1 RCT; 191 participants) · people with non‐alcohol‐related fatty liver disease (NAFLD)
It is very uncertain whether the intervention changes amino acids + vitamin C(1 RCT; 191 participants) (very low certainty).
1 finding from 1 review
OR 1.76 [0.62, 5.53]
Studies not reported
Very low
Intervention not reported
Vitamin D(1 trial; 60 participants) · people with non‐alcohol‐related fatty liver disease (NAFLD)
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Vitamin D(4 trials; 241 participants) · people with non‐alcohol‐related fatty liver disease (NAFLD)
1 finding from 1 review
no estimate extracted
Studies not reported
Very low